Tirzepatide represents a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://lawsonovth415573.glifeblog.com/39246519/tirzepatide-a-new-frontier-in-diabetes-treatment